EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Nanotechnology-Based Cisplatin Delivery for ORL Cancers: A Comprehensive Review

Anda Ioana Morgovan, Eugen Radu Boia, Alexandru Catalin Motofelea, Alexandru Orasan, Mihaela Cristina Negru iD, Kristine Guran, Diana Maria Para, Daniela Sandu, Sonja Ciocani, Adrian Mihail Sitaru, Nicolae Constantin Balica iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26115261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anda Ioana Morgovan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ear, Nose and Throat, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timisoara, 2 Eftimie Murgu Sq., 300041 Ti…. Hauptthemen laut MEDLINE: Cisplatin, Antineoplastic Agents, Drug Delivery Systems, Nanotechnology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy, Timișoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Otorhinolaryngological (ORL) cancers, including malignancies of the oral cavity, pharynx, and larynx, show significant challenges in oncology. Cisplatin, a platinum-based chemotherapy drug, remains a cornerstone of treatment but is often limited by systemic toxicity and resistance. A comprehensive literature review was conducted using recent studies and clinical trials focused on nanotechnology-based cisplatin delivery systems. The analysis covered various types of nanocarriers, their mechanisms, and advantages. Additionally, the limitations of nanotechnology-based cisplatin delivery systems were discussed. Findings indicate that lipid-based nanoparticles, polymeric nanoparticles, inorganic nanoparticles, and extracellular vesicles have demonstrated improved drug targeting, bioavailability, and reduced systemic toxicity in preclinical and clinical studies. Nanocarriers also offer potential for overcoming drug resistance and enabling combination therapy. However, challenges related to biocompatibility, scalability, and regulatory approval remain significant barriers to widespread clinical adoption. Nanotechnology offers a novel and promising approach to optimizing cisplatin delivery for ORL cancers. While preclinical studies demonstrate significant potential, further research and clinical validation are essential to translate these advancements into routine clinical practice. Addressing manufacturing and regulatory challenges will be critical for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAntineoplastic AgentsDrug Delivery SystemsNanotechnologyHumansNanoparticlesAnimalsDrug Carriers

Stichwörter der Autor:innen

ORL cancersbiotechnologycisplatinnanocarriers

Substanzen

CisplatinAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Ear, Nose and Throat, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timisoara, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania.
  • Center for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • OncoHelp Cancer Centre, Radiation Oncology Department, "Victor Babeș" University of Medicine and Pharmacy, Str. Rusu Sireanu nr. 34 Timisoara, 300041 Timisoara, Romania.
  • Department of Pediatric Surgery, "Louis Turcanu" Emergency Clinical Hospital for Children, Iosif Nemoianu Street 2, 300011 Timisoara, Romania.

ORCID-Profile: Mihaela Cristina Negru, Nicolae Constantin Balica

Förderung

  • Victor Babes University of Medicine and Pharmacy, Timișoara

Zitieren

APA

Morgovan, A. I., Boia, E. R., Motofelea, A. C., Orasan, A., Negru, M. C., Guran, K., Para, D. M., Sandu, D., Ciocani, S., Sitaru, A. M., & Balica, N. C. (2025). Advances in Nanotechnology-Based Cisplatin Delivery for ORL Cancers: A Comprehensive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115261

Vancouver

Morgovan AI, Boia ER, Motofelea AC, Orasan A, Negru MC, Guran K, et al. Advances in Nanotechnology-Based Cisplatin Delivery for ORL Cancers: A Comprehensive Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115261

BibTeX
@article{Morgovan2025,
  author = {Morgovan, Anda Ioana and Boia, Eugen Radu and Motofelea, Alexandru Catalin and Orasan, Alexandru and Negru, Mihaela Cristina and Guran, Kristine and Para, Diana Maria and Sandu, Daniela and Ciocani, Sonja and Sitaru, Adrian Mihail and Balica, Nicolae Constantin},
  title = {Advances in Nanotechnology-Based Cisplatin Delivery for ORL Cancers: A Comprehensive Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26115261}
}
Kostenlos starten →